Health ❯ Healthcare ❯ Medical Research

Oncology

Lung Cancer Breast Cancer Pancreatic Cancer Prostate Cancer Glioblastoma Colorectal Cancer Acute Myeloid Leukemia Clinical Trials Multiple Myeloma Immunotherapy

3 ARTICLES

last mo.

Can‑Fite Reports Safe Phase 2a Readout and Survival Signals for Namodenoson in Advanced Pancreatic Cancer

The company plans a Phase 2b trial combining Namodenoson with chemotherapy to test preclinical evidence that the drug increases tumor chemosensitivity.

3 ARTICLES

last mo.

Fibroblasts Explain Why Lung Cancer Subtypes Respond Differently to Anti‑Angiogenic Drugs

4 ARTICLES

2mo ago

Tango’s PRMT5 Inhibitor Plus Daraxonrasib Shows 92% Response in Biomarker‑Selected Pancreatic Cancer

4 ARTICLES

2mo ago

Tumor Inflammation Drives Early Resistance to KRAS Drugs, Study Shows

5 ARTICLES

2mo ago

Sacituzumab Tirumotecan With Keytruda Improves Progression-Free Survival in China Phase 3 Lung Cancer Trial

3 ARTICLES

2mo ago

Boehringer’s Zongertinib Wins China Conditional Approval as ASCO Data Show Patient Benefit and Broader Activity

5 ARTICLES

3mo ago

GLP-1 Drugs Linked to Lower Death and Recurrence in Breast Cancer, Large Study Finds

11 ARTICLES

3mo ago

AI Trained on Swedish Health Registries Flags Small Groups at High Melanoma Risk

8 ARTICLES

4mo ago

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

3 ARTICLES

4mo ago

Experimental Pill Doubles Survival in Advanced Pancreatic Cancer Trial

3 ARTICLES

4mo ago

Cadonilimab Plus Chemo Delivers Strong Phase 2 Signal in Frontline Endometrial Cancer

7 ARTICLES

4mo ago

Androgen Signaling Drives Lethal Pediatric Ependymoma, Study Finds

4 ARTICLES

6mo ago

Study Links PSMA PET/CT to 5-Year Outcomes, Informing Salvage Treatment After Prostatectomy

7 ARTICLES

6mo ago

CNIO’s Triple-Drug Mouse Breakthrough on Pancreatic Cancer Moves Into a Cautious Preclinical Phase

3 ARTICLES

6mo ago

CRISPR Scan Maps the Strength of Cancer-Driving CTNNB1 Hotspot Mutations

Oncology

Can‑Fite Reports Safe Phase 2a Readout and Survival Signals for Namodenoson in Advanced Pancreatic Cancer

Fibroblasts Explain Why Lung Cancer Subtypes Respond Differently to Anti‑Angiogenic Drugs

Tango’s PRMT5 Inhibitor Plus Daraxonrasib Shows 92% Response in Biomarker‑Selected Pancreatic Cancer

Tumor Inflammation Drives Early Resistance to KRAS Drugs, Study Shows

Sacituzumab Tirumotecan With Keytruda Improves Progression-Free Survival in China Phase 3 Lung Cancer Trial

Boehringer’s Zongertinib Wins China Conditional Approval as ASCO Data Show Patient Benefit and Broader Activity

GLP-1 Drugs Linked to Lower Death and Recurrence in Breast Cancer, Large Study Finds

NEJM Study and FDA Access Advance Daraxonrasib for Pancreatic Cancer

AI Blood Test Maps Tumor Neighborhoods and Predicts Immunotherapy Response

AI Pathomics Tool Beats PD-L1 at Predicting Lung Cancer Immunotherapy Benefit

Never miss stories about

Oncology

Pre-Surgery Pembrolizumab Shows Zero Relapses in MSI-High Bowel Cancer Trial

Zoldonrasib Shows Promising Early Efficacy in KRAS G12D Lung Cancer

AI Trained on Swedish Health Registries Flags Small Groups at High Melanoma Risk

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

Experimental Pill Doubles Survival in Advanced Pancreatic Cancer Trial

Cadonilimab Plus Chemo Delivers Strong Phase 2 Signal in Frontline Endometrial Cancer

Androgen Signaling Drives Lethal Pediatric Ependymoma, Study Finds

Study Links PSMA PET/CT to 5-Year Outcomes, Informing Salvage Treatment After Prostatectomy

CNIO’s Triple-Drug Mouse Breakthrough on Pancreatic Cancer Moves Into a Cautious Preclinical Phase

CRISPR Scan Maps the Strength of Cancer-Driving CTNNB1 Hotspot Mutations

Never miss stories about

Oncology